INDIAGLYCO NSE filing

India Glycols Presents Investor Deck Highlighting Demerger & Growth

The RealCase readMedium impact Positive

India Glycols Limited presented an investor deck on September 2, 2026, detailing its demerger into three listed entities. The company targets 10X sales and profits in ten years, driven by sustainable chemistry. Revenue saw a ~13% CAGR and EBITDA ~28% CAGR from FY24-FY26. The demerger aims for sharpened focus and value unlock.

Why it matters

The investor presentation and demerger announcement provide significant strategic information about the company's future direction and structure, which is material for investors.

The market read

The announcement highlights strategic growth initiatives, a clear vision for the future, and positive financial performance indicators, suggesting a positive outlook for the company.

India Glycols Limited (IGL) has released an investor presentation for a meeting held on September 2, 2026, detailing its business structure, financial highlights, and strategic vision, particularly in light of its demerger.

The company is undergoing a demerger to create three independently listed entities: IGL Spirits Limited (housing spirits and biofuels), Ennature Bio Pharma Ltd (nutraceuticals, APIs, and biopolymers), and the remaining India Glycols Limited (focusing on Bio-based Specialty Materials, Sustainable & Performance Chemicals, and Gases).

The demerger, effective September 1, 2026, aims for sharper business focus, enhanced competitiveness, and improved capital allocation. IGL projects a strong growth trajectory, with a vision of achieving 10X sales and profits in ten years, driven by sustainable specialty materials, performance chemicals, and novel technologies.

Financial highlights indicate a revenue CAGR of approximately 13% from FY24 to FY26, with EBITDA growing at a CAGR of around 28%. The company emphasizes its strong foundation in green chemistry, with 97% renewable raw material usage and a leading position in bio-based products. Key business segments include Bio-Glycols, Bio-Glycol Ethers, Performance Chemicals, Industrial Gases, and a joint venture with Clariant for renewable performance chemicals. The company also highlights its logistical advantages, including a direct rail line to the port at its Kashipur facility.

Primary source

A plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.

View original filing
This is RealCase

Every move, explained.

Expert model portfolios with exact weights, an Active or Hold state on every holding, and a written reason behind every change. In your pocket.

Coming soon toApp StoreComing soon toGoogle Play
100% digital · your money stays in your own broker · your data is secure
RealCase
Your RealCases
Core Compounders
Stocks
13.4%
Flexi Core
Mutual Funds
13.1%
Latest change
ActiveHDFC Bank10% → 14%

“Deposits growing faster than loans again. We add on strength, funded from cash.”

₹0Commission · fee-only